Xenon Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
49,276.00
84,041.00
58,651.00
64,146.00
43,667.00
119,306
Total Accounts Receivable
440.00
215.00
315.00
200.00
438.00
256
Other Current Assets
153.00
686.00
1,900.00
1,329.00
716.00
1,875
Total Current Assets
49,869.00
84,942.00
60,866.00
65,675.00
44,821.00
121,437
Net Property, Plant & Equipment
1,879.00
2,476.00
1,989.00
1,404.00
1,070.00
991
Other Assets
2,739.00
-
1,094.00
408.00
230.00
-
Total Assets
54,487.00
87,418.00
63,949.00
67,487.00
46,121.00
122,428
ST Debt & Current Portion LT Debt
-
-
-
-
700.00
Accounts Payable
391.00
553.00
1,088.00
1,463.00
1,253.00
Other Current Liabilities
17,812.00
13,733.00
1,694.00
2,053.00
2,130.00
Total Current Liabilities
18,203.00
14,286.00
2,782.00
3,516.00
4,083.00
Long-Term Debt
-
-
-
-
6,104.00
Other Liabilities
12,168.00
353.00
133.00
70.00
-
Total Liabilities
30,371.00
14,639.00
2,915.00
3,586.00
10,187.00
Common Equity (Total)
78,372.00
72,779.00
61,034.00
63,901.00
35,934.00
Total Shareholders' Equity
24,116.00
72,779.00
61,034.00
63,901.00
35,934.00
Total Equity
24,116.00
72,779.00
61,034.00
63,901.00
35,934.00
Liabilities & Shareholders' Equity
54,487.00
87,418.00
63,949.00
67,487.00
46,121.00
Preferred Stock (Carrying Value)
102,488.00
-
-
-
-
About Xenon Pharmaceuticals
View Profile
